National Cancer Institute; Notice of Closed Meetings, 19088 [2015-08131]

Download as PDF 19088 Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices (https://www.fda.gov/ScienceResearch/ SpecialTopics/RegulatoryScience/ ucm267719.htm). Date and Time: The public workshop will be held on May 27, 2015, from 8:30 a.m. to 3:45 p.m. and May 28, 2015, from 8:30 a.m. to 4 p.m. Location: The public workshop will be held at FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993– 0002. Entrance for the public workshop participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to https:// www.fda.gov/AboutFDA/ WorkingatFDA/BuildingsandFacilities/ WhiteOakCampusInformation/ ucm241740.htm. Contact Person: Leslie Wheelock, Office of Scientific Professional Development, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 4345, Silver Spring, MD, 301–796–4580, FAX: 301–847–8106, email: FDASciProDev@fda.hhs.gov. Registration: Submit your online registration information (including name, title, firm name, address, telephone and email) by May 15, 2015 at: https://www.fda.gov/scienceresearch/ aboutscienceresearchatfda/ ucm429403.htm. There is no registration fee for the public workshop. Early registration is recommended because seating is limited. There will be no onsite registration. If you need special accommodations due to a disability, please contact Leslie Wheelock (see Contact Person) at least 7 days in advance. Webcast: Please be advised that as soon as possible after the Forum, a webcast and report of the public workshop will be accessible at: https:// www.fda.gov/scienceresearch/ aboutscienceresearchatfda/ ucm429403.htm. Each session of the FDA Science Forum will have an expert in the area and presentations by FDA staff. Rmajette on DSK2VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: April 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–08156 Filed 4–8–15; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 15:13 Apr 08, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4) and 552b(c) (6), title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Outstanding Investigator Award 1. Date: April 29, 2015. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 6W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Michael B. Small, Ph.D., Chief, Program and Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W522, Bethesda, MD 20892, 240–276–6438, smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Targeted Radionuclide Therapy. Date: May 4, 2015. Time: 10:00 a.m. to 6:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240–276–6341, vollbert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI R01 Review. Date: May 21, 2015. Time: 1:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, MD 20850, (Telephone Conference Call). PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE Review. Date: June 8–9, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review Officer, Research Program Review Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W116, Bethesda, MD 20892–9750, 240–276–6459, biancoc@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: April 3, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–08131 Filed 4–8–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 80, Number 68 (Thursday, April 9, 2015)]
[Notices]
[Page 19088]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08131]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Outstanding Investigator Award 1.
    Date: April 29, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 6W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Michael B. Small, Ph.D., Chief, Program and 
Review Extramural Staff Training Office, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W522, Bethesda, MD 20892, 240-276-6438, smallm@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Targeted Radionuclide Therapy.
    Date: May 4, 2015.
    Time: 10:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Rockville, MD 20850, 240-276-6341, 
vollbert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R01 Review.
    Date: May 21, 2015.
    Time: 1:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE Review.
    Date: June 8-9, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division Of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W116, Bethesda, MD 20892-9750, 240-276-6459, 
biancoc@mail.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: April 3, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-08131 Filed 4-8-15; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.